Non-bleeding Adverse Events with the Use of Direct Oral Anticoagulants: A Sequence Symmetry Analysis.
Géric MauraCécile BillionnetJoël CosteAlain WeillAnke NeumannAntoine ParientePublished in: Drug safety (2018)
Results of this nationwide study suggest that DOACs are associated with rare but severe liver injury and more frequent gastrointestinal disorders. A low risk of kidney injury with DOAC therapy can also not be excluded.